UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034561
Receipt number R000038270
Scientific Title An open-label, uncontrolled study of ADAPT system in femoral trochanter fracture surgery
Date of disclosure of the study information 2018/11/05
Last modified on 2020/05/15 12:14:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An open-label, uncontrolled study of ADAPT system in femoral trochanter fracture surgery

Acronym

An open-label, uncontrolled study of ADAPT system in femoral trochanter fracture surgery

Scientific Title

An open-label, uncontrolled study of ADAPT system in femoral trochanter fracture surgery

Scientific Title:Acronym

An open-label, uncontrolled study of ADAPT system in femoral trochanter fracture surgery

Region

Japan


Condition

Condition

Patients who are scheduled to use the gamma 3 locking nail system in osteosynthesis at the Nagoya Medical Center orthopedic surgery who was diagnosed as a femoral trochanter fracture

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the usefulness of ADAPT (the gamma 3 rocking nail intraoperative support system) in patients with a femoral trochanter fracture

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Irradiation time

Key secondary outcomes

(1)Operation time
(2)Fracture type
(3)TAD (Tip-apex distance; sum of the distance between the front of the femoral head and the tip of the implant)
(4)Repetition position
(5)Adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Intervention by surgical technique using ADAPT in femoral trochanter fracture treatment.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Diagnosed with a femoral trochanter fracture by imaging and able to use the gamma 3 locking nail system for osteosynthesis
(2) Those who can receive operation
within 4 weeks after injury.
(3) Aged 20 years or older at the time of consent
(4) Provided written consent by themselves after full explanation to participate in this study

Key exclusion criteria

(1)Patients judged by the principal investigator to be inappropriate as subjects

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichi Mori

Organization

National Hospital Organization Nagoya Medical Center

Division name

Orthopedic Surgery and Rheumatology

Zip code


Address

4-1-1,Sannomaru,Naka-ku,Nagoya-shi, Aichi, 460-0001, Japan

TEL

052-951-1111

Email

k-mori@nnh.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koichi Mori

Organization

National Hospital Organization Nagoya Medical Center

Division name

Orthopedic Surgery and Rheumatology

Zip code


Address

4-1-1,Sannomaru,Naka-ku,Nagoya-shi, Aichi, 460-0001, Japan

TEL

052-951-1111

Homepage URL


Email

k-mori@nnh.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Nagoya Medical Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Nagoya Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独立行政法人 国立病院機構 名古屋医療センター(愛知県)


Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 08 Month 15 Day

Date of IRB

2018 Year 08 Month 15 Day

Anticipated trial start date

2018 Year 11 Month 05 Day

Last follow-up date

2020 Year 05 Month 11 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 18 Day

Last modified on

2020 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038270


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name